TAYLOR CRAIG C

CIK 00009391058 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0000939105

Recent Transactions

50 trades

Award
Venus Concept Inc.$VERO
Stock Option (Right to Buy)
2018-06-13+13,708→ 13,708 total
Conversion
Venus Concept Inc.$VERO
Series A Preferred Stock
2017-10-16−461,717→ 0 total
Conversion
Venus Concept Inc.$VERO
Series B Preferred Stock
2017-10-16−505,580→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+12,466→ 12,466 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+13,650→ 26,116 total
Conversion
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-16→ 0 total
Conversion
Venus Concept Inc.$VERO
Series C Preferred Stock
2017-10-16−633,094→ 0 total
Conversion
Venus Concept Inc.$VERO
Series B Preferred Stock
2017-10-16−519,230→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16$7.00/sh+84,526→ 1,668,269 total
Conversion
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-16→ 0 total
Conversion
Venus Concept Inc.$VERO
Series B Preferred Stock
2017-10-16−13,650→ 0 total
Conversion
Venus Concept Inc.$VERO
Series A Preferred Stock
2017-10-16−474,184→ 0 total
Conversion
Venus Concept Inc.$VERO
Series A Preferred Stock
2017-10-16−12,466→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+633,094→ 1,626,508 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+474,184→ 474,184 total
Conversion
Venus Concept Inc.$VERO
Series C Preferred Stock
2017-10-16−16,643→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16$7.00/sh+86,809→ 1,713,317 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+519,230→ 993,414 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+616,446→ 1,583,743 total
Conversion
Venus Concept Inc.$VERO
Series C Preferred Stock
2017-10-16−616,446→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+505,580→ 967,297 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+461,717→ 461,717 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16$7.00/sh+2,282→ 45,041 total
Conversion
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-16→ 0 total
Conversion
Venus Concept Inc.$VERO
Common Stock
2017-10-16+16,643→ 42,759 total
Other
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-11$604351.76/sh
Other
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-11$15888.66/sh
Other
Venus Concept Inc.$VERO
Convertible Promissory Note
2017-10-11$588463.10/sh
Award
ADEZA BIOMEDICAL CORP
stock option (right-to-buy)
2006-06-06+7,500→ 7,500 total
Award
Solexa, Inc.
Common Stock
2006-01-13$10.74/sh+1,949→ 10,252 total
Award
ADEZA BIOMEDICAL CORP
stock option (right-to-buy)
2005-06-09+7,500→ 7,500 total
Exercise/Conversion
ADEZA BIOMEDICAL CORP
Common Stock
2005-05-25$0.32/sh+1,880→ 466,915 total
Exercise/Conversion
ADEZA BIOMEDICAL CORP
Stock Option (right to buy)
2005-05-25−1,880→ 0 total
Conversion
MMRGlobal, Inc.
Series B-2 Convertible Preferred Stock
2005-02-07−427,945→ 0 total
Purchase
MMRGlobal, Inc.
Common Stock
2005-02-07$7.00/sh+714,285→ 2,832,524 total
Conversion
MMRGlobal, Inc.
Common Stock
2005-02-07+2,070,048→ 2,118,239 total
Conversion
MMRGlobal, Inc.
Series C Convertible Preferred Stock
2005-02-07−558,754→ 0 total
Conversion
MMRGlobal, Inc.
Series B Convertible Preferred Stock
2005-02-07−553,029→ 0 total
Conversion
MMRGlobal, Inc.
Series A Convertible Preferred Stock
2005-02-07−481,926→ 0 total
Award
PHARMACYCLICS INC
Option (right to buy Stock)
2004-12-17+7,500→ 7,500 total
Disposition to Issuer
ADEZA BIOMEDICAL CORP
Series 4 Preferred Stock
2004-12-15−73,289→ 0 total
Disposition to Issuer
ADEZA BIOMEDICAL CORP
Series 1 Preferred Stock
2004-12-15−136,735→ 0 total
Conversion
ADEZA BIOMEDICAL CORP
Common Stock
2004-12-15+89,352→ 89,352 total
Conversion
ADEZA BIOMEDICAL CORP
Common Stock
2004-12-15+64,794→ 64,794 total
Conversion
ADEZA BIOMEDICAL CORP
Common Stock
2004-12-15+102,551→ 102,551 total
Disposition to Issuer
ADEZA BIOMEDICAL CORP
Series 2 Preferred Stock
2004-12-15−119,137→ 0 total
Disposition to Issuer
ADEZA BIOMEDICAL CORP
Series 2 Preferred Stock
2004-12-15−353,223→ 0 total
Disposition to Issuer
ADEZA BIOMEDICAL CORP
Series 5 Preferred Stock
2004-12-15−21,598→ 0 total
Conversion
ADEZA BIOMEDICAL CORP
Common Stock
2004-12-15+54,996→ 54,996 total
Conversion
ADEZA BIOMEDICAL CORP
Common Stock
2004-12-15+66,832→ 66,832 total

Companies

Recent Filings

Address

400 HAMILTON AVENUE, 4TH FLOOR

PALO ALTO, CA, 94301

View on SEC.gov